What is the current Price Target for the Tenax Therapeutics, Inc. stock?

The average Tenax Therapeutics, Inc. target price is $20.40. This is 177.93% higher than the current stock price. The highest price target is 329.16%, the lowest is 92.64%. 6 Analysts have issued a price target Tenax Therapeutics, Inc. 2026 .

How high will the Tenax Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Tenax Therapeutics, Inc. stock will rise. The performance of stocks, including the Tenax Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Tenax Therapeutics, Inc. stock today?

The performance of Tenax Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Tenax Therapeutics, Inc. stock fall?

The decline in Tenax Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Tenax Therapeutics, Inc. Forecast, price target & analysts

$7.17

2.32% today

Nasdaq, Nov 03, 04:48 pm CET

ISIN

US88032L2097

Symbol

TENX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Tenax Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Tenax Therapeutics, Inc. Classifications & Recommendation:

Buy

91%

Hold

Tenax Therapeutics, Inc. Price Target

Target Price	$20.40
Price	$7.34
Potential	177.93% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Tenax Therapeutics, Inc. 2026 . The average Tenax Therapeutics, Inc. target price is $20.40. This is 177.93% register free of charge higher than the current stock price. The highest price target is $31.50 329.16% register free of charge , the lowest is $14.14 92.64% register free of charge .
	A rating was issued by 11 analysts: 10 Analysts recommend Tenax Therapeutics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Tenax Therapeutics, Inc. stock has an average upside potential 2026 of 177.93% register free of charge . Most analysts recommend the Tenax Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.15	-1.26
	96.30%	9.57%
P/E		negative

7 Analysts have issued a Tenax Therapeutics, Inc. forecast for earnings per share. The average Tenax Therapeutics, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.15	96.30%
2025	$-1.26 9.57% Unlock
2026	$-1.44 14.29% Unlock
2027	$-1.41 2.08% Unlock
2028	$-1.47 4.26% Unlock
2029	$-0.78 46.94% Unlock
2030	$1.08 238.46% Unlock
2031	$3.62 235.19% Unlock
2032	$6.02 66.30% Unlock

Current	-9.29	33.01%
2025	-5.83 37.25% Unlock
2026	-5.10 12.52% Unlock
2027	-5.22 2.35% Unlock
2028	-5.00 4.21% Unlock
2029	-9.38 87.60% Unlock
2030	6.79 172.39% Unlock
2031	2.03 70.10% Unlock
2032	1.22 39.90% Unlock

Tenax Therapeutics, Inc....

Current Tenax Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Piper Sandler	Locked ➜ Locked	Locked	Sep 08 2025
Guggenheim	Locked ➜ Locked	Locked	Aug 14 2025
Leerink Partners	Locked ➜ Locked	Locked	Oct 24 2024
Guggenheim	Locked ➜ Locked	Locked	Oct 14 2024
William Blair	Locked ➜ Locked	Locked	Sep 30 2024

Analyst Rating	Date
Locked Piper Sandler: Locked ➜ Locked	Sep 08 2025
Locked Guggenheim: Locked ➜ Locked	Aug 14 2025
Locked Leerink Partners: Locked ➜ Locked	Oct 24 2024
Locked Guggenheim: Locked ➜ Locked	Oct 14 2024
Locked William Blair: Locked ➜ Locked	Sep 30 2024

Discover more stocks with a high price target

TUI 51.99%

Adidas 48.21%

Deutsche Telekom 44.14%

Novo Nordisk 42.05%

BYD 37.26%

Meta Platforms (Facebook) 36.95%

BioNTech SE - ADR 34.48%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now